Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline
- PMID: 20962021
- PMCID: PMC3038479
- DOI: 10.1210/jc.2010-1642
Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline
Abstract
Context: The Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) cohort represents the largest and best-characterized national sample of American youth with recent-onset type 2 diabetes.
Objective: The objective of the study was to describe the baseline characteristics of participants in the TODAY randomized clinical trial.
Design: Participants were recruited over 4 yr at 15 clinical centers in the United States (n = 704) and enrolled, randomized, treated, and followed up 2-6 yr.
Setting: The study was conducted at pediatric diabetes care clinics and practices.
Participants: Eligible participants were aged 10-17 yr inclusive, diagnosed with type 2 diabetes for less than 2 yr and had a body mass index at the 85th percentile or greater.
Interventions: After baseline data collection, participants were randomized to one of the following groups: 1) metformin alone, 2) metformin plus rosiglitazone, or 3) metformin plus a lifestyle program of weight management.
Main outcome measures: Baseline data presented include demographics, clinical/medical history, biochemical measurements, and clinical and biochemical abnormalities.
Results: At baseline the cohort included the following: 64.9% were female; mean age was 14.0 yr; mean diabetes duration was 7.8 months; mean body mass index Z-score was 2.15; 89.4% had a family history of diabetes; 41.1% were Hispanic, 31.5% were non-Hispanic black; 38.8% were living with both biological parents; 41.5% had a household annual income of less than $25,000; 26.3% had a highest education level of parent/guardian less than a high school degree; 26.3% had a blood pressure at the 90th percentile or greater; 13.6% had a blood pressure at the 95th percentile or greater; 13.0% had microalbuminuria; 79.8% had a low high-density lipoprotein level; and 10.2% had high triglycerides.
Conclusions: The TODAY cohort is predominantly from racial/ethnic minority groups, with low socioeconomic status and a family history of diabetes. Clinical and biochemical abnormalities and comorbidities are prevalent within 2 yr of diagnosis. These findings contribute greatly to our understanding of American youth with type 2 diabetes.
References
-
- Pinhas-Hamiel O, Zeitler P 2005 The global spread of type 2 diabetes in children and adolescents. J Pediatr 146:693–700 - PubMed
-
- Neufeld ND, Rafael LJ, Landon C, Chen YD, Vadheim CM 1998 Early presentation of type 2 diabetes in Mexican-American youth. Diabetes Care 21:80–86 - PubMed
-
- Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P 1996 Increased incidence of non-insulin dependent diabetes mellitus among adolescents. J Pediatr 128:608–615 - PubMed
-
- Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, Beckles G, Saaddine J, Gregg EW, Williamson DF, Narayan KM 2000 Type 2 diabetes among North American children and adolescents: an epidemiological review and public health perspective. J Pediatr 136:664–672 - PubMed
-
- Dabelea D, Bell RA, D'Agostino Jr RB, Imperatore G, Johansen JM, Linder B, Liu LL, Loots B, Marcovina S, Mayer-Davis EJ, Pettitt DJ, Waitzfelder B; SEARCH for Diabetes in Youth Study Group 2007 Incidence of diabetes in youth in the United States. JAMA 297:2716–2724 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UL1-RR024153/RR/NCRR NIH HHS/United States
- UL1 RR024153/RR/NCRR NIH HHS/United States
- U01-DK61239/DK/NIDDK NIH HHS/United States
- UL1 RR025780/RR/NCRR NIH HHS/United States
- M01 RR000036/RR/NCRR NIH HHS/United States
- U01 DK061212/DK/NIDDK NIH HHS/United States
- M01 RR014467/RR/NCRR NIH HHS/United States
- U01 DK061230/DK/NIDDK NIH HHS/United States
- M01-RR00036/RR/NCRR NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
- M01 RR000084/RR/NCRR NIH HHS/United States
- M01-RR00043-45/RR/NCRR NIH HHS/United States
- U01 DK061254/DK/NIDDK NIH HHS/United States
- UL1 RR024139/RR/NCRR NIH HHS/United States
- UL1 RR024989/RR/NCRR NIH HHS/United States
- M01-RR00125/RR/NCRR NIH HHS/United States
- U01-DK61242/DK/NIDDK NIH HHS/United States
- M01 RR000069/RR/NCRR NIH HHS/United States
- U01-DK61254/DK/NIDDK NIH HHS/United States
- U01-DK61212/DK/NIDDK NIH HHS/United States
- UL1-RR025758/RR/NCRR NIH HHS/United States
- UL1-RR024989/RR/NCRR NIH HHS/United States
- U01 DK061242/DK/NIDDK NIH HHS/United States
- U01-DK61230/DK/NIDDK NIH HHS/United States
- UL1 RR024992/RR/NCRR NIH HHS/United States
- M01-RR01066/RR/NCRR NIH HHS/United States
- M01 RR001066/RR/NCRR NIH HHS/United States
- UL1-RR024139/RR/NCRR NIH HHS/United States
- UL1-RR025780/RR/NCRR NIH HHS/United States
- UL1-RR024992/RR/NCRR NIH HHS/United States
- M01 RR000043/RR/NCRR NIH HHS/United States
- UL1-RR024134/RR/NCRR NIH HHS/United States
- M01-RR00069/RR/NCRR NIH HHS/United States
- M01-RR14467/RR/NCRR NIH HHS/United States
- M01 RR000125/RR/NCRR NIH HHS/United States
- U01 DK061239/DK/NIDDK NIH HHS/United States
- UL1 RR024134/RR/NCRR NIH HHS/United States
- M01-RR00084/RR/NCRR NIH HHS/United States
